|
1) Bugianesi E. Non-alcoholic steatohepatitis and cancer. In: Younossi ZM, Gitlin N, editors. Clinics in Liver Disease Vol. 11, No. 1. Philadelphia: Elsevier Inc; 2007. p. 191-207
|
|
|
|
|
2) Villanueva C, Piqueras M, Aracil C, et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol. 2006; 45: 560-7
|
|
|
|
|
3) Takuma Y, Nouso K, Takayama H, et al. Gastric ulcer after prophylactic balloon-occluded retrograde transvenous obligation. J Gastroenterol. 2007; 42: 257-60
|
|
|
|
|
4) Tanoue S, Kiyosue H, Matsumoto S, et al. Development of a new coaxial balloon catheter system for balloon-occluded retrograde transvenous obligation (B-RTO). Cardiovasc Intervent Radiol. 2006; 29: 991-6
|
|
|
|
|
|
5) 加藤章信, 小野寺誠, 鈴木一幸. 肝性脳症とインターベンション. 日門亢会誌. 2006; 12: 248-52
|
|
|
|
|
|
6) 吉松英輝, 高塚健太郎, 岩淵省吾. 部分的脾動脈塞栓術における門脈血行動態の変化と血清アルブミン値に関する検討. 肝臓. 2007; 48: 153-60
|
|
|
|
|
7) 山崎正晴, 瓦谷英人, 松村雅彦, 他. 難治性腹水におけるVEGF familyの検討. 日門亢会誌. 2006; 12: 228-33
|
|
|
|
|
|
8) Esteva-Font C, Baccaro MF, Fernandez-Llama P, et al. Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: relationship with ascites and hepatorenal syndrome. Hepatology. 2006; 44: 1555-63
|
|
|
|
|
|
9) Grover VPB, Dresner MA, Forton DM, et al. Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J Gastroenterol. 2006; 12: 2969-78
|
|
|
|
|
|
10) Ciecko-Michlska I, Sendereecka M, Szewczyk J, et al. Event-related cerebral potentials for the diagnosis of subclinical hepatic encephalopathy in patients with liver cirrhosis. Adv Med Sci. 2006; 51: 273-7
|
|
|
|
|
|
11) Pichile VBR, Rao KVR, Jayakumar AR, et al. Inhibition of glutamine transport into mitochondria protects astrocytes from ammonia toxicity. Glia. 2007; 55: 801-9
|
|
|
|
|
|
12) Abdel-Hady H, Zaki A, Badra G, et al. Helicobacter pylori infection in hepatic encephalopathy: relationship to plasma endotoxins and blood ammonia. Hepatol Res. 2007; 37: 1026-33
|
|
|
|
|
|
13) Rimar D, Kruzel-Davila E, Dori G, et al. Hyper-ammonemic coma-barking up the wrong tree. JGIM. 2007; 22: 549-52
|
|
|
|
|
|
14) Cholongitas E, Marelli L, Kerry A, et al. Different methods of creatinine measurement significantly affect MELD score. Liver Transpl. 2007; 13: 523-9
|
|
|
|
|
|
15) 森 広樹, 阿部哲史, 石川雅邦, 他. C型肝炎ウイルス陽性レシピエントに対するペグインターフェロンとリバビリン併用療法の成績. 肝胆膵. 2006; 52: 85-90
|
|
|
|
|
|
16) 清澤研道, 松本晶博, 田中栄司, 他. B型慢性肝炎に対するラミブジン治療調査報告-2005-. 犬山シンポジウム記録刊行会, 編. ウイルス肝炎からの発癌とその予防. 東京: アークメディア; 2005. p. 159-65
|
|
|
|
|
|
17) Nakamura M, Kotoh K, Enjoji M, et al. Effect of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients. Comparative Hepatology. 2007; 6: 3
|
|
|
|
|
|
18) Fartoux L, Degos F, Trepo C, et al. Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trial. Clin Gastroenterol Hepatol. 2007; 5: 502-7
|
|
|
|
|
|
19) Mazzaferro V, Romito R, Schiavo M, et al. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology. 2006; 44: 1543-54
|
|
|
|
|
|
20) Lo CM, Liu CL, Chan SC, et al. A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg. 2007; 245: 831-42
|
|
|
|
|
|
21) Takahashi H, Kato A, Onodera K, et al. Fasting plasma ghrelin levels reflect malnutrition state in patients with liver cirrhosis. Hepatol Res. 2006; 34: 117-23
|
|
|
|
|
|
22) Muto Y, Sato S, Watanabe A, et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Cli Gastroenterol Hepatol. 2005; 3: 705-13
|
|
|
|
|
|
23) Muto Y, Sato S, Watanabe A, et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res. 2006; 35: 204-14
|
|
|
|
|
|
24) Pekow JR, Bhan AK, Zheng Hui, et al. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer. 2007; 109: 2490-6
|
|
|
|
|
|
25) Nishida T, Tsuji S, Tsujii M, et al. Oral glucose tolerance test predicts prognosis of patients with live cirrhosis. Am J Gastroenterol. 2006; 101: 70-5
|
|
|
|
|
|
26) Nakaya Y, Okita K, Suzuki K, et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition. 2007; 23: 113-20
|
|
|
|
|
|
27) Aoyama K, Tsuchiya M, Mori K, et al. Effect of a late evening snack on outpatients with liver cirrhosis. Hepatol Res. 2007; 37: 608-14
|
|
|
|
|
|
28) Hayashi M, Ikezawa K, Ono A, et al. Evaluation of the effect of combination therapy with branched-chain amino acid and zinc supplementation on nitrogen metabolism in liver cirrhosis. Hepatol Res. 2007; 37: 615-9
|
|
|
|
|
|
29) Tanaka N, Horiuchi A, Yamaura T, et al. Efficacy and safety of 6-month iron reduction therapy in patienys with hepatitis C virus-related cirrhosis: a pilot study. J Gastroenterol. 2007; 42: 49-55
|
|
|
|
|